Evidence map›Paper›PMID 28680886›Full record

ArticleBioMed research international2017

The Phosphatase Inhibitor Calyculin-A Impairs Clot Retraction, Platelet Activation, and Thrombin Generation.

Renáta Hudák, János Vincze, László Csernoch, Ildikó Beke Debreceni, Tamás Oláh, Ferenc Erdődi, Kenneth J Clemetson, János Kappelmayer

Open access · hybridAbstract read
In one paragraph

Article in BioMed research international, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Effect of Yiqi Huoxue Granules on Platelet Activation Induced by Thrombin.Evidence-based complementary and alternative medicine : eCAM · 2021
    Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Renáta HudákDepartment of Laboratory Medicine, Faculty of Medicine, University of Debrecen, 98 Nagyerdei krt., Debrecen 4032, Hungary.
János VinczeDepartment of Physiology, Faculty of Medicine, University of Debrecen, 98 Nagyerdei krt., Debrecen 4032, Hungary.
László CsernochDepartment of Physiology, Faculty of Medicine, University of Debrecen, 98 Nagyerdei krt., Debrecen 4032, Hungary.
Ildikó Beke DebreceniDepartment of Laboratory Medicine, Faculty of Medicine, University of Debrecen, 98 Nagyerdei krt., Debrecen 4032, Hungary.
Tamás OláhDepartment of Physiology, Faculty of Medicine, University of Debrecen, 98 Nagyerdei krt., Debrecen 4032, Hungary.
Ferenc ErdődiDepartment of Medical Chemistry, Faculty of Medicine, University of Debrecen, 98 Nagyerdei krt., Debrecen 4032, Hungary.
Kenneth J ClemetsonDepartment of Hematology, Inselspital, University of Bern, Murtenstrasse 40, 3008 Bern, Switzerland.
János KappelmayerDepartment of Laboratory Medicine, Faculty of Medicine, University of Debrecen, 98 Nagyerdei krt., Debrecen 4032, Hungary.ORCID 0000-0002-3599-4717
University of Debrecen · HUUniversity of Bern · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of this study was to investigate the effect of the serine/threonine protein phosphatase inhibitor, calyculin-A (CLA), on clot formation and on the procoagulant activity of human platelets. Platelet-rich plasma (PRP) samples were preincubated with buffer or CLA and subsequently platelets were activated by the protease-activated receptor 1 (PAR-1) activator, thrombin receptor activating peptide (TRAP). Clot retraction was detected by observing clot morphology up to 1 hour, phosphatidylserine- (PS-) expression was studied by flow cytometry, and thrombin generation was measured by a fluorimetric assay. For the intracellular Ca

Indexed as

Blood PlateletsEnzyme InhibitorsFemaleFibrinolysisFlow CytometryHumansMaleMarine ToxinsOxazolesPlatelet Activationcalyculin AEnzyme InhibitorsMarine ToxinsOxazoles

Identifiers

PMID28680886
PMCPMC5478853
OpenAlexW2621734636

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.